Milligan PE - Search Results

1

Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratio.

Banet GA, Waterman AD, Milligan PE, Gatchel SK, Gage BF. Banet GA, et al. Among authors: milligan pe. Chest. 2003 Feb;123(2):499-503. doi: 10.1378/chest.123.2.499. Chest. 2003. PMID: 12576372 Clinical Trial.

2

Substitution of generic warfarin for Coumadin in an HMO setting.

Milligan PE, Banet GA, Waterman AD, Gatchel SK, Gage BF. Milligan PE, et al. Ann Pharmacother. 2002 May;36(5):764-8. doi: 10.1345/aph.1A327. Ann Pharmacother. 2002. PMID: 11978149 Clinical Trial.

3

Risk factors for bleeding in patients taking coumarins.

Beyth RJ, Milligan PE, Gage BF. Beyth RJ, et al. Among authors: milligan pe. Curr Hematol Rep. 2002 Sep;1(1):41-9. Curr Hematol Rep. 2002. PMID: 12901124 Review.

4

Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.

Gage BF, Eby C, Milligan PE, Banet GA, Duncan JR, McLeod HL. Gage BF, et al. Among authors: milligan pe. Thromb Haemost. 2004 Jan;91(1):87-94. doi: 10.1160/TH03-06-0379. Thromb Haemost. 2004. PMID: 14691573

5

Effect of warfarin nonadherence on control of the International Normalized Ratio.

Waterman AD, Milligan PE, Bayer L, Banet GA, Gatchel SK, Gage BF. Waterman AD, et al. Among authors: milligan pe. Am J Health Syst Pharm. 2004 Jun 15;61(12):1258-64. doi: 10.1093/ajhp/61.12.1258. Am J Health Syst Pharm. 2004. PMID: 15259756

6

Prospective dosing of warfarin based on cytochrome P-450 2C9 genotype.

Voora D, Eby C, Linder MW, Milligan PE, Bukaveckas BL, McLeod HL, Maloney W, Clohisy J, Burnett RS, Grosso L, Gatchel SK, Gage BF. Voora D, et al. Among authors: milligan pe. Thromb Haemost. 2005 Apr;93(4):700-5. doi: 10.1160/TH04-08-0542. Thromb Haemost. 2005. PMID: 15841315

7

Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).

Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW, Radford MJ. Gage BF, et al. Among authors: milligan pe. Am Heart J. 2006 Mar;151(3):713-9. doi: 10.1016/j.ahj.2005.04.017. Am Heart J. 2006. PMID: 16504638

8

Genetic-based dosing in orthopedic patients beginning warfarin therapy.

Millican EA, Lenzini PA, Milligan PE, Grosso L, Eby C, Deych E, Grice G, Clohisy JC, Barrack RL, Burnett RS, Voora D, Gatchel S, Tiemeier A, Gage BF. Millican EA, et al. Among authors: milligan pe. Blood. 2007 Sep 1;110(5):1511-5. doi: 10.1182/blood-2007-01-069609. Epub 2007 Mar 26. Blood. 2007. PMID: 17387222 Free PMC article. Clinical Trial.

9

Optimal initial dose adjustment of warfarin in orthopedic patients.

Lenzini PA, Grice GR, Milligan PE, Gatchel SK, Deych E, Eby CS, Burnett RS, Clohisy JC, Barrack RL, Gage BF. Lenzini PA, et al. Among authors: milligan pe. Ann Pharmacother. 2007 Nov;41(11):1798-804. doi: 10.1345/aph.1K197. Epub 2007 Oct 2. Ann Pharmacother. 2007. PMID: 17911206

10

Patient and physician satisfaction with a telephone-based anticoagulation service.

Waterman AD, Banet G, Milligan PE, Frazier A, Verzino E, Walton B, Gage BF. Waterman AD, et al. Among authors: milligan pe. J Gen Intern Med. 2001 Jul;16(7):460-3. doi: 10.1046/j.1525-1497.2001.016007460.x. J Gen Intern Med. 2001. PMID: 11520383 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters